Clinical trial
Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)
NCT00231439 · Haukeland University Hospital, Other · Completed
Key facts
| NCT number | NCT00231439 |
|---|---|
| Title | Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg) |
| Official title | Post-Polio Syndrome Treated With Intravenous Immunoglobulin (IvIg) |
| Lead sponsor | Haukeland University Hospital, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Post-Polio Syndrome |
| Intervention type | Drug |
| Interventions | IvIg |
| Enrollment | 40 |
| Start date | Aug 1, 2003 |
| Completion | Jul 1, 2004 |
| First posted | Oct 4, 2005 |
| Last update posted | Dec 13, 2005 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: